Augmented duodenal levels of sodium/glucose co-transporter 1 are associated with higher risk of nonalcoholic fatty liver disease and noninvasive index of liver fibrosis-Reference-Cited by-同舟云学术

Augmented duodenal levels of sodium/glucose co-transporter 1 are associated with higher risk of nonalcoholic fatty liver disease and noninvasive index of liver fibrosis

Published:2022-03 Issue: Volume:185 Page:109789
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Fiorentino Teresa Vanessa,De Vito Francesca,Suraci Evelina,Marasco Raffaella,Catalano Federica,Andreozzi Francesco,Hribal Marta Letizia,Luzza Francesco,Sesti Giorgio

Funder

Società Italiana di Medicina Interna

Eli Lilly and Company

European Foundation for the Study of Diabetes

Ministero dell’Istruzione, dell’Università e della Ricerca

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference41 articles.

1. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology,2016

2. Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis;Younossi;Hepatology,2019